Ouhtit A, Nakazawa H, Armstrong B K, Kricker A, Tan E, Yamasaki H, English D R
Unit of Multistage Carcinogenesis, International Agency for Research on Cancer, Lyon, France.
J Natl Cancer Inst. 1998 Apr 1;90(7):523-31. doi: 10.1093/jnci/90.7.523.
A strong association has been found between skin cancer and exposure to UV radiation. The p53 tumor suppressor gene (also known as TP53), which is frequently mutated in human cancers, is believed to be an early target in UV radiation-associated skin carcinogenesis. We have previously developed a sensitive, polymerase chain reaction-based method capable of detecting and quantifying a UV radiation-specific mutation in the p53 gene (codons 247 and 248: AAC CGG --> AAT TGG) in normal skin. We have used this method to examine whether UV radiation-specific mutation frequency is associated with risk of basal cell carcinoma (BCC) and with sun exposure.
This case-control study in Australia involved 53 case subjects with BCC and 75 control subjects. DNA was isolated from normal skin (mirror-image anatomic site to the cancer site for case subjects and a randomly selected site for control subjects) and assayed for p53 mutation. Relationships between p53 mutation frequency and risk of BCC, sun sensitivity, or sun exposure were estimated by use of odds ratios (ORs) and 95% confidence intervals (95% CIs).
Case subjects were more likely to have a p53 mutation than control subjects (OR = 3.1; 95% CI = 1.3-7.1). In addition, the odds of BCC increased monotonically with increasing frequency of p53 mutation. No statistically significant associations could be demonstrated between p53 mutation frequency and age, sex, sensitivity to the sun, pigmentary characteristics, total lifetime sun exposure, or sun exposure to the biopsy site.
Our results indicate that tandem CC --> TT mutations involving codons 247 and 248 of the p53 gene are associated with an increased risk of BCC but cannot be used as an accurate measure of total UV-radiation exposure.
皮肤癌与紫外线辐射暴露之间已发现存在密切关联。p53肿瘤抑制基因(也称为TP53)在人类癌症中经常发生突变,被认为是紫外线辐射相关皮肤致癌作用的早期靶点。我们之前开发了一种基于聚合酶链反应的灵敏方法,能够检测和定量正常皮肤中p53基因(密码子247和248:AAC CGG --> AAT TGG)的紫外线辐射特异性突变。我们已使用该方法来研究紫外线辐射特异性突变频率是否与基底细胞癌(BCC)风险以及阳光暴露有关。
这项在澳大利亚开展的病例对照研究纳入了53例BCC病例受试者和75例对照受试者。从正常皮肤(病例受试者为癌症部位的镜像解剖部位,对照受试者为随机选择的部位)提取DNA,并检测p53突变。通过优势比(OR)和95%置信区间(95%CI)来评估p53突变频率与BCC风险、阳光敏感性或阳光暴露之间的关系。
病例受试者比对照受试者更有可能发生p53突变(OR = 3.1;95%CI = 1.3 - 7.1)。此外,BCC的发病几率随着p53突变频率的增加而单调增加。在p53突变频率与年龄、性别、对阳光的敏感性、色素沉着特征、一生总的阳光暴露量或活检部位的阳光暴露之间,未发现有统计学意义的关联。
我们的结果表明,涉及p53基因密码子247和248的串联CC --> TT突变与BCC风险增加相关,但不能用作总紫外线辐射暴露的准确衡量指标。